Results 211 to 220 of about 125,056 (333)

Intestinal and multiple organ transplantation [PDF]

open access: yes, 2005
Abu-Elmagd, K   +3 more
core  

COVID-19 coagulopathy [PDF]

open access: yesCleveland Clinic Journal of Medicine, 2020
openaire   +2 more sources

Antithrombin (AT) and Recombinant Human Thrombomodulin (rhTM) Combination as New Therapeutic Breakthrough in Managing Sepsis-Induced Coagulopathy (SIC)

open access: gold, 2019
John P. Nolan   +3 more
openalex   +1 more source

Localized Consumptive Coagulopathy [PDF]

open access: bronze, 2001
Michael A. Scola   +2 more
openalex   +1 more source

Association of a Platelet Shortage with process and clinical outcomes

open access: yesTransfusion, EarlyView.
Abstract Background Little is known about how platelet shortages impact patient care and outcomes. In the summer of 2024, a ransomware event substantially impacted blood product processing capacity in South Florida, creating a natural experiment to evaluate such a shortage.
Hayley B. Gershengorn   +7 more
wiley   +1 more source

Cefazolin-induced coagulopathy: a case report. [PDF]

open access: yesJ Med Case Rep
Zerbib O   +4 more
europepmc   +1 more source

Endothelial thrombomodulin—Its role in trauma‐induced coagulopathy

open access: yesTransfusion, EarlyView.
Abstract Background Trauma‐induced coagulopathy (TIC) describes a complex set of coagulation changes affecting severely injured patients. The thrombomodulin‐protein C axis is central to the evolution of TIC. Soluble thrombomodulin (sTM) levels are elevated after injury and predict poor clinical outcomes.
Jeries Abu‐Hanna   +7 more
wiley   +1 more source

Pathogen‐reduced plasma, cryoprecipitate reduced for therapeutic plasma exchange

open access: yesTransfusion, EarlyView.
Abstract Background Therapeutic plasma exchange (TPE) for thrombotic thrombocytopenic purpura (TTP) and auto‐immune disorders involves repeated patient exposure to allogenic plasma with the risk of transfusion‐transmitted infection (TTI).
Florian Tupin   +6 more
wiley   +1 more source

High Rate of Cytokine Release Syndrome-Related Coagulopathy with Low Incidence of Bleeding and Thrombosis in Patients Treated with B-Cell Maturation Antigen (BCMA)-Targeted Chimeric Antigen Receptor T-Cells (CAR-T). [PDF]

open access: yesCancers (Basel)
Arad A   +13 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy